Summer 2024 Vol. 14 Issue 02
-
From the Editor-in-Chief
Weight-loss Drugs and CancerObesity and increased cancer risk have been linked. Could new drugs promising to reduce weight also lower the risk of cancer?
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Do You Want a Pet?Even though they come with additional responsibility, pets can be a source of support and comfort during cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Finding Good Help at HomeHome health providers can offer additional assistance, but it can take time to find the right fit.
by K.J. Bannan
-
Policy Matters
Clinical Trial Endpoints for Timely Drug DevelopmentAs patients live longer with cancer, scientists need to rethink how to determine if a new drug is safe and effective.
by Kenneth Anderson, MD
-
Follow the Heart
Oncologists and researchers increasingly focus on how to predict, treat and monitor for cardiovascular problems that develop before and after treatment.
by Stephen Ornes
-
Extending Remissions in Lung Cancer
Immune checkpoint inhibitors are effective against non-small cell lung cancer in some patients. Researchers are investigating who benefits from the drugs and when they should be administered for maximum impact.
by Natalie Slivinski
-
TILs in Solid Tumors
With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
by Kendall K. Morgan
-
Survivor Profile
Being Proactive About Prostate CancerBrian Jones applies lessons he has learned to help other Black men facing the disease.
by Suzanne McBride
-
Q&A
A Life RearrangedBone cancer and facial reconstruction surgeries redefined former opera singer Kathleen Watt’s relationship with her body.
by Ashley P. Taylor
-
Get Involved
Ground SupportHouston-based nonprofit offers free rides to and from medical appointments for people with cancer.
by Thomas Celona
-
Facts and Stats
From Lab Experiment to Lifesaving TreatmentDecades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin